AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.64, payable on Friday, Feb.
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
In 2024, combined Skyrizi and Rinvoq sales reached $17.7 billion, up 51% year over year, reflecting accelerating global ...
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...
AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based ...
Robert Michael will replace former CEO Richard Gonzalez, marking the official end to Gonzalez’s long reign at the pharma ...
In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV ... employee-owned investment management company. Established in 2000 as Lee Munder Capital Group, it has 25 years ...